This information was published on 2025-11-18T09:09:52 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2601336 (IR 1884883) |
| (220) |
07 Oct 2025
|
| (300) |
US, 07 May 2025, 99173108
|
| (511) (510) |
Class 44
Medical screening; medical testing for diagnostic or treatment purposes; DNA screening for medical purposes. |
| (540) | NEURODEVELOPMENTNEXT |
| (550) | Word |
| (730) |
Ambry Genetics Corporation
|
Find out more about publications on the About page.